Seltas Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Kolkata, West Bengal, India, established in 2020.
2020 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Seltas Pharma Private Limited

Seltas Pharma Private Limited, a active private limited company, was established on 12 February 2020 in Kolkata, West Bengal, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100WB2020PTC236411. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Archana Kumari (Director), Tinkal Kumari (Director). Past directors included Sonam Kumari, Anupa Kumari, Sadhana Singh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B/1/H/5, Ripon Square, Kolkata, West Bengal, 700016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100WB2020PTC236411

  • Registration Number

    236411

  • Incorporation Date

    12 February 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** -0.20%
  • Ebitda **** -0.01%
  • Net Worth -28.94%
  • Total Assets **** 26.57%
Company report

Seltas Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Seltas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Seltas Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Archana Kumari Director 03 Jan 2021 Current
Tinkal Kumari Director 17 Apr 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Apr 2023 Past
Pramod Abcsdd Director 20 Dec 2022 Past
Pramod Abcsdd Director 18 Apr 2023 Past
Pramod Abcsdd Director 18 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Seltas Pharma.

Seltas Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 0.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.94%.

Seltas Pharma revenue growth over time
Seltas Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 26.57%
*******
*******
*******
*******
Profit or Loss
*******
 -0.20%
*******
*******
*******
*******
Net Worth
*******
 -28.94%
*******
*******
*******
*******
EBITDA
*******
 -0.01%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Seltas Pharma?

Unlock access to Seltas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Seltas Pharma?

Unlock and access historical data on people associated with Seltas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Seltas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seltas Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Seltas Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Seltas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Seltas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.

  • Director Appointment

    Progress on Tinkal Kumari was appointed as a Director was appointed as a Director on 17 Apr 2023 & has been associated with this company since 2 years 9 months . was documented.

  • Director Appointment

    Archana Kumari was appointed as a Director was appointed as a Director on 03 Jan 2021 & has been associated with this company since 5 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Seltas Pharma Private Limited was registered on 12 Feb 2020 with Roc Kolkata & aged 5 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Seltas Pharma Private Limited?

The CIN of Seltas Pharma Private Limited is U85100WB2020PTC236411.

Where is Seltas Pharma Private Limited headquartered?

Seltas Pharma Private Limited is headquartered at B/1/H/5, Ripon Square, Kolkata, West Bengal, 700016.

When was Seltas Pharma Private Limited incorporated?

Seltas Pharma Private Limited was incorporated on 12 February 2020.

Who are the current directors of Seltas Pharma Private Limited?

The current directors of Seltas Pharma Private Limited are

What is the primary industry of Seltas Pharma Private Limited?

The primary industry of Seltas Pharma Private Limited is Healthcare.

Is Seltas Pharma Private Limited a listed company?

Seltas Pharma Private Limited is unlisted.

What is the capital structure of Seltas Pharma Private Limited?

The authorized capital of Seltas Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available